Table 1.
CRE negative (N=131) | CAD (N=48) | CIH (N=46) | p values | |
---|---|---|---|---|
| ||||
Age : years (median, range) | 45 (2–84) | 49 (2–75) | 46.5(2–74) | 0.9 |
| ||||
Gender (Male /Female) | 83/48 | 35/13 | 33/13 | 0.4 |
| ||||
Diagnosis | 0.02 | |||
ALL | 25 | 11 | 08 | |
AML | 21 | 17 | 20 | |
LYMPHOMA | 54 | 12 | 10 | |
MM | 147 | 05 | 03 | |
OTHERS | 1 | 03 | 05 | |
| ||||
ECOG- PS (median, range) | 2 (0–4) | 2 (1–4) | 2 (0–4) | 0.2 |
| ||||
CCI (median, range) | 3 (0–5) | 3.5 (0–5) | 3 (0–4) | 0.1 |
| ||||
Hospital stay (median, range) | 5 (1–25) | 8 (1–28) | 26 (1–64) | 0.001 |
| ||||
CRE -RM | 0 | 3 | 14 | 0.0001 |
| ||||
IRM | 0 | 5 | 17 | 0.0001 |
Abbreviations: AL: Acute Leukemia; ALL: Acute Lymphoblastic Leukemia, AML: Acute Myeloid Leukemia, CRE: Carbapenem-resistant Enterobacteriaceae; CCI: Charlson Comorbidity Index; CRE: Carbapenem Resistant Enterobacteriaceae; CAD: CRE at diagnosis; CIH-CRE in hospital; CRE-RM: CRE related mortality; ECOG-PS: Eastern Cooperative Oncology Group- Performance Status, IRM: Infection related mortality; MM: Multiple Myeloma.